Intervention not reported
Responder rate (1‐ to 3‐month blinded evaluation period) · patients with refractory (multi)focal or generalized epilepsy
The intervention showed no clear difference in responder rate (1‐ to 3‐month blinded evaluation period) (low certainty).
1 finding from 1 review
Intervention not reported
Responder rate (3‐month blinded evaluation period) · adults with IQ > 70 with refractory focal epilepsy
The intervention showed no clear difference in responder rate (3‐month blinded evaluation period) (moderate certainty).
1 finding from 1 review
Intervention not reported
Responder rate (3‐month blinded evaluation period) · adults with IQ >70 with refractory focal epilepsy
The intervention showed no clear difference in responder rate (3‐month blinded evaluation period) (low certainty).
1 finding from 1 review
OR 10 [0.53, 189.15]
1 study · 4 participants
Low
Intervention not reported
Responder rate (3‐month blinded evaluation period) · adults with refractory focal epilepsy (1 or 2 epileptogenic regions)
The intervention showed no clear difference in responder rate (3‐month blinded evaluation period) (moderate certainty).
1 finding from 1 review
Intervention not reported
Responder rate (3‐month blinded evaluation period) · patients with refractory (multi)focal or generalized epilepsy
It is very uncertain whether the intervention changes responder rate (3‐month blinded evaluation period) (very low certainty).
1 finding from 1 review
OR 1 [0.27, 3.69]
1 study · 6 participants
Very low
Intervention not reported
Responder rate (1‐ to 3‐month blinded evaluation periods) · patients with refractory medial temporal lobe epilepsy
The intervention showed no clear difference in responder rate (1‐ to 3‐month blinded evaluation periods) (low certainty).
1 finding from 1 review